Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Waystar HoldingWAY +2.12%14 Debt-to-EBITDA is 3.05 as of Mar. 2026, which is 57% below its 10-year median of 7.06. GuruFocus rates WAY with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Waystar Holding ranks worse than 65.69% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Waystar Holding's Debt-to-EBITDA or its related term are showing as below:
WAY'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.6 Med: 7.06 Max: 9.71
Current: 3.6
During the past 5 years, the highest Debt-to-EBITDA Ratio of Waystar Holding was 9.71. The lowest was 3.60. And the median was 7.06.
WAY's Debt-to-EBITDA is ranked worse than 65.69% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs WAY: 3.60
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Waystar Holding Debt-to-EBITDA Related Terms
Waystar Holding Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Waystar Holding's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAY vs DOCS, PRVA, HTFL: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, Waystar Holding's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Waystar Holding Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Waystar Holding's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Waystar Holding's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Waystar Holding (WAY) has a Debt-to-EBITDA of 3.05 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Waystar Holding. This is 57% below median its historical median of 7.06. Over the past decade, Waystar Holding's Debt-to-EBITDA has ranged from 3.60 to 9.71. According to the industry distribution chart, Waystar Holding ranks #314 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 65.7%.
Is Waystar Holding's Debt-to-EBITDA too high?
Waystar Holding's current Debt-to-EBITDA of 3.05 is 57% below median its 10-year median of 7.06. Over the past 10 years, this metric has ranged from a low of 3.60 to a high of 9.71. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. Waystar Holding's value of 3.05 is 35.6% above this industry median. Based on the distribution chart, Waystar Holding ranks #314 out of 478 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Waystar Holding has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Waystar Holding's Debt-to-EBITDA compare to DOCS and PRVA?
According to the Healthcare Providers & Services industry distribution chart, Waystar Holding ranks #314 out of 478 companies for Debt-to-EBITDA. This places Waystar Holding in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. Waystar Holding's value of 3.05 is 35.6% above this benchmark. Historically, Waystar Holding's own Debt-to-EBITDA has ranged from 3.60 to 9.71 over the past decade. While the company's 10-year median is 7.06 vs. the industry median of 2.25, Waystar Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Waystar Holding's current Debt-to-EBITDA of 3.05 is 35.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Waystar Holding. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Waystar Holding's current Debt-to-EBITDA is 3.05, which is 57% below median its own 10-year median of 7.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Waystar Holding stock overvalued right now?
Waystar Holding (WAY) has a current Debt-to-EBITDA of 3.05. The current Debt-to-EBITDA is 3.05, which is 57% below median its 10-year median of 7.06 and 35.6% above the Healthcare Providers & Services industry median of 2.25. Waystar Holding's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Waystar Holding (WAY), the current Debt-to-EBITDA is 3.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
14GF Score
Get the complete analysis for WAY
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAY has been successfully added to your 
